Hepcinat & Natdac (Sofosbuvir/ Daclatasvir) online

$269.00

In stock

269.00 per 28 Tablets

Compare

Sofosbuvir and Daclatasvir are hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use: • Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving DAKLINZA in combination with sofosbuvir for 12 weeks.

See It Styled On Instagram

    Instagram did not return any images.

Main Menu